Zimmer Biomet Holdings Net Income 2006-2018 | ZBH

Zimmer Biomet Holdings annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Zimmer Biomet Holdings net income for the quarter ending September 30, 2018 was $0.162B, a 64.17% increase year-over-year.
  • Zimmer Biomet Holdings net income for the twelve months ending September 30, 2018 was $1.753B, a 168.91% increase year-over-year.
  • Zimmer Biomet Holdings annual net income for 2017 was $1.814B, a 492.94% increase from 2016.
  • Zimmer Biomet Holdings annual net income for 2016 was $0.306B, a 108.1% increase from 2015.
  • Zimmer Biomet Holdings annual net income for 2015 was $0.147B, a 79.59% decline from 2014.
Zimmer Biomet Holdings Annual Net Income
(Millions of US $)
2017 $1,814
2016 $306
2015 $147
2014 $720
2013 $780
2012 $755
2011 $761
2010 $597
2009 $717
2008 $849
2007 $773
2006 $835
2005 $733
Zimmer Biomet Holdings Quarterly Net Income
(Millions of US $)
Q3 2018 $162
Q2 2018 $185
Q1 2018 $175
Q4 2017 $1,231
Q3 2017 $99
Q2 2017 $184
Q1 2017 $299
Q4 2016 $70
Q3 2016 $159
Q2 2016 $-31
Q1 2016 $109
Q4 2015 $127
Q3 2015 $22
Q2 2015 $-174
Q1 2015 $171
Q4 2014 $149
Q3 2014 $173
Q2 2014 $177
Q1 2014 $222
Q4 2013 $255
Q3 2013 $154
Q2 2013 $152
Q1 2013 $219
Q4 2012 $153
Q3 2012 $178
Q2 2012 $215
Q1 2012 $210
Q4 2011 $157
Q3 2011 $192
Q2 2011 $204
Q1 2011 $209
Q4 2010 $35
Q3 2010 $191
Q2 2010 $166
Q1 2010 $205
Q4 2009 $155
Q3 2009 $150
Q2 2009 $210
Q1 2009 $202
Q4 2008 $168
Q3 2008 $215
Q2 2008 $227
Q1 2008 $239
Q4 2007 $264
Q3 2007 $45
Q2 2007 $232
Q1 2007 $233
Q4 2006 $245
Q3 2006 $183
Q2 2006 $201
Q1 2006 $206
Q4 2005 $200
Q3 2005 $169
Q2 2005 $191
Q1 2005 $174
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.875B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00